A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy

Based on SMPCs and (inter)national guidance documents and recommendations a care pathway has been developed and visualized in a Metro Map. This provides a clear and comprehensive overview of all activities, contact moments, and responsibilities within the longitudinal gene therapy treatment process. This comprehensive care pathway may help navigate gene therapy implementation, providing guidance to clinicians, patients, and caregivers.

Authors

Institutions

Publication Details

Journal
Journal of Thrombosis and Haemostasis
Published
2025-10-27
DOI
https://doi.org/10.1016/j.jtha.2025.09.041
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy

Frank W.G. Leebeek, Alok Srivastava, Radosław Kaczmarek, Flora Peyvandi et al.
Journal of Thrombosis and Haemostasis
Hemophilia Treatment and Research
article

A comprehensive care pathway of gene therapy for hemophilia based on current guideline documents and summary of product characteristics: communication from the ISTH SSC working group on gene therapy

Frank W.G. Leebeek, Alok Srivastava, Radosław Kaczmarek, Flora Peyvandi, David Lillicrap, Pratima Chowdary, Ilaria Cutica, Jan Voorberg, Glenn F. Pierce, Wolfgang Miesbach, Johnny Ndoni Mahlangu, Caroline Mussert, Paul Batty, Amit Nathwani, Steven W Pipe
article en

Abstract

Based on SMPCs and (inter)national guidance documents and recommendations a care pathway has been developed and visualized in a Metro Map. This provides a clear and comprehensive overview of all activities, contact moments, and responsibilities within the longitudinal gene therapy treatment process. This comprehensive care pathway may help navigate gene therapy implementation, providing guidance to clinicians, patients, and caregivers.

Journal of Thrombosis and HaemostasisVol. 24(2)
Twitter (United States) (US), Goethe University Frankfurt (DE), University of Milan (IT), University of the Witwatersrand (ZA), Queen's University (CA), University of Michigan (US), The Royal Free Hospital (GB), Canadian Hemophilia Society (CA), Erasmus MC (NL), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Sanquin (NL), University Hospital Frankfurt (DE), Erasmus MC - Sophia Children’s Hospital (NL), St.John's Medical College Hospital (IN), Ludwik Hirszfeld Institute of Immunology and Experimental Therapy (PL), University College London (GB), Indiana University – Purdue University Indianapolis (US), Erasmus University Rotterdam (NL)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Openalex Percentile: Top 61%
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.